Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(20 sites)

United States

Cardiology PC, Birmingham, Alabama

Arizona Cardiovascular Research Center, Phoenix, Arizona

Scripps Health, La Jolla, California

University of California, San Francisco, San Francisco, California

Bluhm Cardiovascular Institute of Northwestern University, Chicago, Illinois

University of Chicago Medical Center, Chicago, Illinois

Prairie Education and Research Cooperative, Springfield, Illinois

Ascension St. Vincent - Cardiovascular Research Institute, Indianapolis, Indiana

Cardiovascular Institute of the South, Houma, Louisiana

Michigan Medicine, University of Michigan, Ann Arbor, Michigan

Mayo Clinic, Rochester, Minnesota

St. Louis Heart and Vascular, St Louis, Missouri

Weill Cornell Medicine, New York, New York

Icahn School of Medicine at Mount Sinai, New York, New York

Columbia University Medical Center, New York, New York

Rochester General Hospital, Rochester, New York

Duke University Medical Center, Durham, North Carolina

Ohio State University Wexner Medical Center, Columbus, Ohio

Medical University of South Carolina, Charleston, South Carolina

Virginia Commonwealth University Medical Center, Richmond, Virginia